| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/24/2009 | CA2717958A1 Dithiocarbamate metal chelates and methods of making and using thereof |
| 09/24/2009 | CA2717899A1 Stable fixed dose topical formulation |
| 09/24/2009 | CA2717679A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/24/2009 | CA2717459A1 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | CA2717440A1 Antiviral formulation |
| 09/24/2009 | CA2716994A1 Pharmaceutical compositions having desirable bioavailability |
| 09/24/2009 | CA2716676A1 Inhibitor for blood phosphorus level elevation |
| 09/24/2009 | CA2715422A1 Compositions for site-specific delivery of imatinib and methods of use |
| 09/24/2009 | CA2715350A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 09/23/2009 | EP2103662A1 Multiple modified derivatives of gelatin and crosslinked material thereof |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103315A2 Sanitary napkins with hydrophobic lotions |
| 09/23/2009 | EP2103313A1 Method for the synthesis of hollow spheres |
| 09/23/2009 | EP2103307A2 Methylphenidate Modified Release Formulations |
| 09/23/2009 | EP2103303A2 Controlled release formulation |
| 09/23/2009 | EP2103302A1 Divisible dosage form allowing modified release of the active principle |
| 09/23/2009 | EP2102267A2 Polypeptides with the capacity to entrap drugs |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101779A1 Medical implants with a combination of compounds |
| 09/23/2009 | EP2101771A2 Stable lercanidipine formulation |
| 09/23/2009 | EP2101770A2 Medicinal delivery system and related methods |
| 09/23/2009 | EP2101767A2 An article comprising prasugrel |
| 09/23/2009 | EP2101757A1 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same |
| 09/23/2009 | EP2101750A2 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 09/23/2009 | EP2101745A1 Delivery of drugs |
| 09/23/2009 | EP2101744A2 Oral transmucosal nicotine dosage form |
| 09/23/2009 | EP2101743A1 Extended release excipient and its use |
| 09/23/2009 | EP2101742A2 Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form |
| 09/23/2009 | EP2101741A2 Solid dispersion comprising a poorly water soluble drug |
| 09/23/2009 | EP2101740A1 New non-abusable pharmaceutical composition comprising opioids |
| 09/23/2009 | EP2101739A2 Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |
| 09/23/2009 | EP2101738A2 Composition of and method for preparing orally disintegrating tablets |
| 09/23/2009 | EP2101737A1 Revaprazan-containing solid dispersion and process for the preparation thereof |
| 09/23/2009 | EP2101736A2 Homogeneous paste and gel formulations |
| 09/23/2009 | EP2101735A2 Nanoparticulate formulations and methods for the making and use thereof |
| 09/23/2009 | EP2101734A2 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 09/23/2009 | EP2101733A2 Powder formulation for valganciclovir |
| 09/23/2009 | EP2101732A2 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 09/23/2009 | EP2101731A2 Endoxifen methods and compositions |
| 09/23/2009 | EP2101730A2 Galenic form for the transmucosal delivery of paracetamol |
| 09/23/2009 | EP2101729A1 Self-microemulsifying drug delivery systems |
| 09/23/2009 | EP2101728A1 Dispersion of polyamino acids in a continuous lipid phase |
| 09/23/2009 | EP2101727A2 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 09/23/2009 | EP2101726A2 New vaseline-free ointment compositions comprising a vitamin d derivative and possibly an anti-inflammatory steroid |
| 09/23/2009 | EP2101725A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops |
| 09/23/2009 | EP2101724A2 Administration of cells and cellular extracts for rejuvenation |
| 09/23/2009 | EP2101713A1 New modules, new assemblage kits and new assemblies for the controlled release of substances |
| 09/23/2009 | EP2101712A1 Process for providing a quantity of a particulate material, product and apparatus |
| 09/23/2009 | EP2101581A2 Veterinary formulation |
| 09/23/2009 | EP1799204B1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 09/23/2009 | EP1768649B1 Pharmaceutical composition of piperazine derivatives |
| 09/23/2009 | EP1621207B1 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 09/23/2009 | EP1435919B1 Device and method for accurate delivery of an active agent |
| 09/23/2009 | EP1420827B1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/23/2009 | EP1416966B1 Methods for treating joint inflammation, pain, and loss of mobility |
| 09/23/2009 | EP1339418B1 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 09/23/2009 | EP1283682B1 Tryptophan source from plants and uses therefor |
| 09/23/2009 | EP1214944B1 Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity |
| 09/23/2009 | EP1044021B1 Enhanced transport using membrane disruptive agents |
| 09/23/2009 | CN201312914Y Anti-cough-asthma patch |
| 09/23/2009 | CN101541315A Antimycotic patch |
| 09/23/2009 | CN101541314A Device for delivering active ingredients to humans, animals and plants |
| 09/23/2009 | CN101541313A Novel injectable depot compositions and process of preparation of such compositions |
| 09/23/2009 | CN101541312A Anionic latex as a carrier for bioactive ingredients |
| 09/23/2009 | CN101541311A Granular preparation prevented from caking |
| 09/23/2009 | CN101541310A Powder formulation for valganciclovir |
| 09/23/2009 | CN101541309A Pharmaceutical formulation comprising neurokinin antagonist |
| 09/23/2009 | CN101541308A Use of glycerophospholipids for joint lubrication |
| 09/23/2009 | CN101541307A Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 09/23/2009 | CN101541306A Microemulsion dosage forms of valsartan and methods of making the same |
| 09/23/2009 | CN101541305A Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
| 09/23/2009 | CN101541304A Ointment compositions comprising a vitamin D derivative |
| 09/23/2009 | CN101541303A Methods and ophthalmic devices used in the treatment of ocular allergies |
| 09/23/2009 | CN101541302A Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 09/23/2009 | CN101541301A Helically-shaped drug delivery system |
| 09/23/2009 | CN101541300A Particle formation |
| 09/23/2009 | CN101541299A Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 09/23/2009 | CN101538312A Preparation and applications of RGD-fatty amine series compound as tumor targeting vector material |
| 09/23/2009 | CN101538303A Natural fatty acid monoester derivatives of cucurbitacin monomers |
| 09/23/2009 | CN101538236A Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
| 09/23/2009 | CN101537191A Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 09/23/2009 | CN101537185A Tumor cell actively targeted drug delivery system, preparation method and application thereof |
| 09/23/2009 | CN101537184A Composition containing water-insoluble high-activity drug and preparation method thereof |
| 09/23/2009 | CN101537177A Drug with thrombus-curing function and preparation method thereof |
| 09/23/2009 | CN101537174A Health preserving calcium |
| 09/23/2009 | CN101537173A Preparations stabilized over long time |
| 09/23/2009 | CN101537172A Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same |
| 09/23/2009 | CN101537171A Preparation method and clinical application of poliosis-treating medicament |
| 09/23/2009 | CN101537167A Menstruation regulating and reproduction assisting paste and preparation method thereof |
| 09/23/2009 | CN101537164A Chinese traditional medicine composition for curing dysmenorrheal and preparation method thereof |
| 09/23/2009 | CN101537163A Chinese traditional medicine composition for curing emphysema and preparation method thereof |
| 09/23/2009 | CN101537162A Chinese traditional medicine for curing Type II diabetes mellitus |
| 09/23/2009 | CN101537161A Chinese patent drug for treating nephritis |
| 09/23/2009 | CN101537160A Health product for toxicant elimination and beauty maintenance |
| 09/23/2009 | CN101537158A Chinese medicinal preparation for treating schizophrenia |
| 09/23/2009 | CN101537157A Chinese medicine for treating esophagus cancer |
| 09/23/2009 | CN101537155A Mongolian preparation for tonifying kidney, invigorating spleen and relieving mental stress and preparation method thereof |
| 09/23/2009 | CN101537152A Pharmaceutical composition for curing acute and chronic nasosinusitis and preparation method thereof |
| 09/23/2009 | CN101537149A Pharmaceutical composition for curing eczema |
| 09/23/2009 | CN101537148A External application drug for curing eczema and preparation method thereof |